Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics

BACKGROUND: The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself. This work aims to study the situation of biomarker testin...

Descripción completa

Detalles Bibliográficos
Autores principales: Provencio, Mariano, Cobo, Manuel, Rodriguez-Abreu, Delvys, Calvo, Virginia, Carcereny, Enric, Cantero, Alexandra, Bernabé, Reyes, Benitez, Gretel, Castro, Rafael López, Massutí, Bartomeu, del Barco, Edel, García Campelo, Rosario, Guirado, Maria, Camps, Carlos, Ortega, Ana Laura, González Larriba, Jose Luis, Sánchez, Alfredo, Casal, Joaquín, Sala, M. Angeles, Juan-Vidal, Oscar, Bosch-Barrera, Joaquim, Oramas, Juana, Dómine, Manuel, Trigo, Jose Manuel, Blanco, Remei, Calzas, Julia, Morilla, Idoia, Padilla, Airam, Pimentao, Joao, Sousa, Pedro A., Torrente, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254518/
https://www.ncbi.nlm.nih.gov/pubmed/35790916
http://dx.doi.org/10.1186/s12885-022-09830-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254518/
https://www.ncbi.nlm.nih.gov/pubmed/35790916
http://dx.doi.org/10.1186/s12885-022-09830-8

Ejemplares similares